Carlos Echiburú-Chau

Carlos Echiburú-Chau

Auto-generated profile, based on publicly available information

Carlos Echiburú-Chau

Instituto de Alta Investigación, Universidad de Tarapacá, Arica, Chile

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Molecular Medicine
Verified
Journal Article
Open access
GWGengyun Wen
Gengyun Wen
GCGloria M. Calaf
Gloria M. Calaf
MPMichael A. Partridge
Michael A. Partridge
CECarlos Echiburú-Chau
Carlos Echiburú-Chau
YZYongliang Zhao
Yongliang Zhao
THTom K. Hei
Tom K. Hei
Human small airway epithelial cells (SAECs) previously immortalized with human telomerase reverse transcriptase (h-TERT) were continuously treated with sodium arsenite at a dose of 0.5 microg/mL in culture for up to 6 months. Arsenic-treated cells progressively displayed an increase in transformed phenotype including enhanced growth saturation density, plating efficiency, and anchorage-independent growth and invasion capability compared with their nontreated control cells. To determine whether arsenic-induced cell transformation was associated with genomic instability, treated and control cells were also analyzed for micronuclei formation. A 4.8-fold increase in micronuclei incidence in arsenic-treated cells was detected in conjunction with increased N-phosphonacetyl-l-aspartate (PALA)-resistant characteristics. In addition, arsenic-treated cells showed an increase in c-H-ras, c-myc, and c-fos protein expression relative to controls. The change in oncoprotein expression correlated with a decrease in wild-type p53 expression and hyperphosphorylated retinoblastoma. Taken together, these results strongly suggest that h-TERT immortalized human small airway epithelial cells underwent step-wise transformation after inorganic arsenic treatment.

6 June 2017 in Natural Product Research
Verified
Journal Article
Closed access
Claudio ParraClaudio Parra
Claudio Parra
ESEmilio Soto
Emilio Soto
GLGloria León
Gloria León
Cristian O. SalasCristian O. Salas
Cristian O. Salas
Michael HeinrichMichael Heinrich
Michael Heinrich
CECarlos Echiburú-Chau
Carlos Echiburú-Chau
Continuing with our study characterising Senecio nutans Sch. Bip., we have isolated and identified a simple coumarin, scopoletin, that could be relevant for the biological properties of the species related with the ancestral medical uses. This is the first report of scopoletin from S. nutans. In addition, the extract was analysed for its antioxidant activity using the ABTS and FRAP method as well as providing the first nutritional analyses of this plant from northern Chile highlands.

1 November 2017 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
CECarlos Echiburu-Chau
Carlos Echiburu-Chau
LPLeyla Pastén
Leyla Pastén
Claudio ParraClaudio Parra
Claudio Parra
JBJorge Bórquez
Jorge Bórquez
Andrei-Marius MocanAndrei-Marius Mocan
Andrei-Marius Mocan
Mario SimirgiotisMario Simirgiotis
Mario Simirgiotis
High-resolution mass spectrometry is currently used to determine the mass of biologically active compounds in medicinal plants and food and UHPLC-Orbitrap is a relatively new technology that allows fast fingerprinting and metabolomics analysis. Forty-two metabolites including several phenolic acids, flavonoids, coumarines, tremetones and ent-clerodane diterpenes were accurately identified for the first time in the resin of the medicinal plant Parastrephia lucida (Asteraceae) a Chilean native species, commonly called umatola, collected in the pre-cordillera and altiplano regions of northern Chile, by means of UHPLC-PDA-HR-MS. This could be possible by the state of the art technology employed, which allowed well resolved total ion current peaks and the proposal of some biosynthetic relationships between the compounds detected. Some mayor compounds were also isolated using HSCCC. The ethanolic extract showed high total polyphenols content and significant antioxidant capacity. Furthermore, several biological assays were performed that determined the high antioxidant capacity found for the mayor compound isolated from the plant, 11- p-coumaroyloxyltremetone.

7 September 2015 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
JBJorge Bórquez
Jorge Bórquez
NBNandy López Bartolucci
Nandy López Bartolucci
CECarlos Echiburú‐Chau
Carlos Echiburú‐Chau
PWPeter Winterhalter
Peter Winterhalter
JVJavier Vallejos
Javier Vallejos
Mario SimirgiotisMario Simirgiotis
Mario Simirgiotis

1 May 2008 in International Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
GCGloria Calaf
Gloria Calaf
CEC. Echiburú-Chau
C. Echiburú-Chau
YZY. L. Zhao
Y. L. Zhao
THTom K Hei
Tom K Hei
The current hypothesis of tumorigenesis in humans suggests that cancer cells acquire their hallmarks of malignancy through the accumulation of advantageous gene activation and inactivation events over long periods of time. For breast cancer development, this multistep process may manifest itself as a sequence of pathologically defined stages. It is widely held that breast cancer originates at the premalignant stage of atypical ductal hyperplasia, progresses to the preinvasive stage of ductal carcinoma in situ, and culminates in the potentially lethal stage of invasive ductal carcinoma. Tumor grade has been a highly valuable prognostic factor for breast cancer, and high-grade ductal carcinoma in situ lesions are associated with poor clinical outcome. The aim of this work was to investigate the BigH3 protein expression changes associated with various stages of breast cancer progression in comparison to benign specimens using tissue microarray technology. Pathological characteristics of breast tissues ranged from benign lesions to breast cancers either of lobular or ductal carcinomas in origin, and included in situ ductal carcinomas, lobular carcinomas, infiltrating ductal carcinomas, carcinomas, scirrhous carcinomas, adenocarcinomas and infiltrating colloid carcinomas. BigH3 protein expression was analyzed by immunohistochemistry in 192 cases of breast tumors. Results indicated a decrease in BigH3 protein expression from benign tissues to in situ ductal carcinoma, lobular carcinoma, infiltrating ductal carcinomas, carcinomas, scirrhous carcinoma, adenocarcinomas to infiltrating colloid carcinomas. We observed that the benign tissue had a 23-fold increase in BigH3 protein expression compared to the infiltrating colloid carcinoma which was the most malignant tissue analyzed. In summary, these studies confirmed the suppressor effect of the BigH3 gene expressed as protein expression in those processes related to the progression of breast tumorigenesis. We conclude that this protein can be used as a marker for breast cancer progression.

17 May 2012 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
GCGloria Calaf
Gloria Calaf
CECarlos Echiburú-Chau
Carlos Echiburú-Chau
Breast cancer is the most frequent malignancy diagnosed in women and is a classical model of hormone-dependent malignancy. Over the past 15-20 years, epidemiological studies have pointed to an increased breast cancer risk associated with prolonged exposure to female hormones. On the other hand, environmental chemicals such as malathion, an organophosphorous pesticide used to control a wide range of sucking and chewing pests of field crops, may be involved in the etiology of breast cancers. Results indicated that estrogen alone increased average number of lobules per mm2 of rat mammary glands in comparison to control and malathion alone at 30, 124, 240 and 400 days after 5-day treatments. On the other hand, malathion alone significantly increased the number of ducts in stage of proliferation at 10-240 days after 5-day treatments. Furthermore, markers for cancer detection such as mutant p53, c-myc, c-fos and CYPs proteins were overexpressed after treatments. Atropine, an anticholinergic drug, counteracted these effects when it was combined with malathion under similar conditions. The combination of malathion and estrogen synergistically increased number of lobules and ducts per mm2 of rat mammary glands after treatments and inducing mammary cancer. It can be concluded that combination of an environmental substance such as the pesticide malathion and an endogenous substance such as estrogen can enhance the deleterious effects in human mammary glands inducing cancer and atropine is able to diminish these effects.